icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL 2017 - European Association for the
Study of the Liver
Amsterdam, The Netherlands. 2017
Back grey_arrow_rt.gif
 
 
 
Sofosbuvir/velpatasvir compared to existing Standards of Care in GT2-6 HCV Real-world experience from the TRIO Network
 
 
  Reported by Jules Levin
EASL 2017 April 19-22 Amsterdam Netherlands
 
Michael Curry1, Bruce Bacon2, Douglas T. Dieterich3, Steven L. Flamm4, Kris Kowdley5, Scott Milligan6, Naoky Tsai7, Zobair Younossi8 and Nezam Afdhal1
 
1Beth Israel Deaconess Medical Center, 2Saint Louis University School of Medicine, 3Icahn School of Medicine at Mount Sinai, 4Northwestern University Feinberg School of Medicine, 5Liver Care Network, Swedish Medical Center, 6Trio Health Analytics, 7Queens Medical Center, University of Hawaii, and 8Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital
 
Reported by Jules Levin
EASL 2017 April 19-22 Amsterdam Netherlands
 
Michael Curry1, Bruce Bacon2, Douglas T. Dieterich3, Steven L. Flamm4, Kris Kowdley5, Scott Milligan6, Naoky Tsai7, Zobair Younossi8 and Nezam Afdhal1
 
1Beth Israel Deaconess Medical Center, 2Saint Louis University School of Medicine, 3Icahn School of Medicine at Mount Sinai, 4Northwestern University Feinberg School of Medicine, 5Liver Care Network, Swedish Medical Center, 6Trio Health Analytics, 7Queens Medical Center, University of Hawaii, and 8Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital

CROI1

CROI2

CROI3

CROI4

CROI5

CROI6